FDA Brief

Warning letters Drugs

FDA warning letter to

DMM Vission, S.A. de C.V.

High riskIssued Jun 3, 2021Posted Jun 8, 2021Center for Drug Evaluation and Research

Mexican maker DMM Vission's hand sanitizers, labeled 70% ethanol, were found at the U.S. border to contain methanol and far less ethanol than stated.

What happened

FDA tested batches of two hand sanitizer products — SYP HEALTH HAND SANITIZER ALCOHOL GEL and Cleaner BY CRYSTALWARE HAND SANITIZER alcohol gel — that were labeled or declared as made at the firm's Mexico facility, after they were detained and refused admission at the U.S. border. The SYP product tested at an average of 31% ethanol and 2.3% methanol, and the Cleaner product at 22% ethanol and 10% methanol, though both labels said 70% ethanol. FDA held a teleconference with the firm on August 21, 2020 and publicly warned consumers; the firm recalled five lots of Cleaner hand sanitizer on September 8, 2020, and a consignee recalled one lot of SYP.

What FDA found

  1. The products were labeled as 70% ethanol but testing found only 22% to 31% ethanol plus methanol, meaning the active ingredient was replaced in whole or in part with a dangerous chemical.

    Section 501(d)(2) of the FD&C Act, 21 U.S.C. 351(d)(2)
  2. That substitution shows the firm's quality assurance is not working as required by current good manufacturing practice (CGMP), the basic quality rules for drug makers.

    Section 501(a)(2)(B) of the FD&C Act, 21 U.S.C. 351(a)(2)(B)
  3. The hand sanitizers are unapproved new drugs sold without an FDA-approved application and do not meet the conditions for marketing without one.

    Section 505(a) of the FD&C Act, 21 U.S.C. 355(a)
  4. The labels are false or misleading because they overstate the ethanol content and do not list methanol as an ingredient.

    Sections 502(a) and 502(e)(1)(A) of the FD&C Act, 21 U.S.C. 352(a), 352(e)(1)(A)
  5. The labels lack the required warning to get medical help or contact a Poison Control Center right away if swallowed.

    Section 502(f)(2) of the FD&C Act, 21 U.S.C. 352(f)(2); 21 CFR 330.1(g)
  6. The SYP product is packaged in a clear, colorless 33.8 fl oz container that looks like a drinking water bottle, which is misleading.

    Section 502(i)(1) of the FD&C Act, 21 U.S.C. 352(i)(1)

What FDA wants

FDA asks the firm to reply in writing within 15 working days with an investigation into how ethanol was replaced with methanol, a list of all raw material suppliers, a full reconciliation of batches shipped to the U.S., and complete batch records. FDA also strongly recommends hiring a qualified CGMP consultant before making drugs for the U.S. market again.

Who should pay attention

  • brands and distributors that buy hand sanitizer from Mexican contract manufacturers
  • retailers and importers selling hand sanitizer labeled 70% ethanol
  • companies sourcing over-the-counter topical antiseptics from Mexico

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. World Perfumes Inc.

    World Perfumes failed to test drug ingredients for toxic contaminants and had inadequate water, FDA says.

    High risk
  2. RNA Bio/Pharma, Incorporated

    FDA found RNA Bio/Pharma failed to test homeopathic oral liquid drugs for dangerous contaminants and did not validate its water system.

    High risk
  3. Kabana Skin Care LLC

    Kabana Skin Care failed to test OTC drug ingredients and finished products, prompting a recall and halt of U.S. drug manufacturing.

    High risk
  4. Ningbo Riway Industrial Co., Ltd.

    Ningbo Riway Industrial, an OTC drug maker in China, was cited for manufacturing-practice failures and unapproved antiseptic wipes.

    High risk